Quick Takeaways
- Robert W. Duggan filed SCHEDULE 13D/A for Pulse Biosciences, Inc. Common Stock, par value $0.001 per share (PLSE).
- Disclosed ownership: 71%.
- Date of event: 18 Dec 2024.
Robert W. Duggan - 18 Dec 2024 SCHEDULE 13D/A Report for Pulse Biosciences, Inc. Common Stock, par value $0.001 per share (PLSE)
- Filing Manager
- Robert W. Duggan
- Reporting Manager
- Robert W. Duggan
- Symbol
- PLSE
- Shares outstanding
- 69,110,956 shares
- Disclosed Ownership
- 48,792,335 shares
- Ownership
- 71%
- Form type
- SCHEDULE 13D/A
- Filing time
- 19 Dec 2024, 06:29:34 UTC
- Date of event
- 18 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Robert W. Duggan disclosed 71% ownership in Pulse Biosciences, Inc. Common Stock, par value $0.001 per share (PLSE) on 18 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 Dec 2024, 06:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Robert W. Duggan | 71% | 48,792,335 | 48,792,335 | 0 | /s/ Robert W. Duggan | Robert W. Duggan | 0001055919 |
| GENIUS 24C INC | 0.9% | 630,109 | 630,109 | 0 | /s/ Martin Brittner | Martin Brittner, Chief Operating Officer | |
| Blazon Corporation | 0.7% | 450,189 | 450,189 | 0 | /s/ Robert W. Duggan | Robert W. Duggan, Authorized Signatory |